Foresite Capital Management I Reveals 5.6% Position in Karyopharm Therapeutics

Foresite Capital Management I disclosed, in a new filing with the SEC, a new passive stake in Karyopharm Therapeutics Inc (NASDAQ:KPTI), which amasses...

Keep Reading →